See also this year's filing and all EDGAR filings for this company.
PDF Report 0001549595_2023_Nurix_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001549595, Nurix Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 318,449,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 17,163,000 |
| 3 | remainder_Assets | 81,147,000 |
| 4 | LiabilitiesCurrent | 70,655,000 |
| 5 | LiabilitiesNoncurrent | 42,408,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 37,997,000 |
| 9 | ResearchAndDevelopmentExpense | 184,497,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 42,134,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -3,711,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 416,759,000 |
| 1 | Liabilities | 113,063,000 |
| 2 | Expenses | 222,494,000 |
| 3 | Revenues | 42,134,000 |
| 4 | StockholdersEquity | 303,696,000 |
| 5 | NetIncome | -180,360,000 |
| 6 | ComprehensiveNetIncome | -182,215,500 |
| 7 | BaseVar | 399,080,500 |
| 8 | EconomicCapitalRatio | 1.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
